In exciting news for Alzheimer's patients and their families, the FDA plans to relax the rules for approving new treatments for the disease.
Dr. Gregg Shalan, a neurologist from Methodist Dallas Medical Center discusses what that decision means for those whose lives have been touched by Alzheimer's.
